Comprehend Joins The Avoca Quality Consortium™ to Share Quality and Compliance Insights for Clinical Trials

Share Article

Comprehend Systems, the leader in Clinical Intelligence software, today announced its membership in The Avoca Quality Consortium (AQC), a collaborative focused on quality management in clinical outsourcing, cementing a long-standing relationship with The Avoca Group to support clinical trial metrics and insights on quality and oversight.

"We welcome Comprehend as a new AQC Member and look forward to working together as part of our collaboration model to further both quality and compliance initiatives.” said Patricia Leuchten, President and CEO, The Avoca Group.

Comprehend Systems, the leader in Clinical Intelligence software, today announced its membership in The Avoca Quality Consortium (AQC), a collaborative focused on quality management in clinical outsourcing, cementing a long-standing relationship with The Avoca Group to support clinical trial metrics and insights on quality and oversight. With the advent of the ICH E6 (R2) addendum, quality and oversight are spotlighted areas of interest for pharmaceutical and biotech companies. Both Comprehend and the AQC are focused on providing relevant leading practices and metrics to assist these companies in addressing efficacy, vendor relationships, patient safety and regulatory compliance.

“Avoca’s deep industry standard guidance is well recognized in life sciences,” said Rick Morrison, CEO of Comprehend. “Many of the leading sponsors with whom we work follow Avoca’s advice and strategy, and we are delighted to be a part of the Avoca Quality Consortium to continue to support these sponsors in their roadmap to achieve clinical trial excellence.”

“Avoca and Comprehend are aligned with the mission to improve quality, speed, and efficiency in clinical trial execution, and Comprehend is making a difference in clinical research through their innovative technology to enable insights into clinical trials,” said Patricia Leuchten, President and CEO, The Avoca Group. “Recently, Avoca and Comprehend collaborated on a webinar focused on oversight, where both companies demonstrated leading practices and expertise in helping the industry to be compliant with ICH E6 (R2). We welcome Comprehend as a new AQC Member and look forward to working together as part of our collaboration model to further both quality and compliance initiatives.”

Comprehend’s Software-as-a-Service for Clinical Intelligence includes specific KPIs, dashboards and scorecards to assist sponsors in their efforts to manage trial quality and CRO Oversight. As an add-on to the ClinOps Insights application, the CRO Oversight capabilities reduce time, cost and risk. They help sponsors better manage shared data, reporting and issue resolution, while enabling an automated method of collaboration between sponsors and CROs.

About The Avoca Group, Inc.
The Avoca Group is an integrated research and consulting firm providing survey research, consulting services, and training in the areas of clinical trial outsourcing, strategic alliances and quality management. Sponsors of clinical research and clinical research organizations have benefited from quantitative and qualitative perception data gathered by The Avoca Group from sites about their reciprocal working relationships. The company’s focus is to help solve complex clinical trial challenges through innovative solutions and to improve the quality and efficiency of clinical trial execution. Founded in 1999, the company works exclusively in the healthcare industry and has a focus on clinical research and clinical outsourcing. http://www.theavocagroup.com

About Comprehend Systems, Inc.
Comprehend offers a suite of Clinical Intelligence applications that enables ClinOps Execs, Data Managers and Medical Monitors to significantly improve the speed, safety and quality of a portfolio of clinical trials. Across studies, sites, systems and CROs, Comprehend's Clinical Intelligence Suite is particularly effective for centralized monitoring, risk monitoring, CRO oversight and collaboration, data review and medical monitoring initiatives. With powerful capabilities to intelligently unify, monitor, and analyze clinical data across CROs, studies and systems, Comprehend gives life sciences companies the ability to address the most difficult and complex FDA guidelines for quality, risk and oversight. Comprehend: the speed to quality results. http://www.Comprehend.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Carolyn Hughes